Back

Summary Estimates Derived from a Multi-state Non-Markov Framework to Characterize the Course of Heart Disease

Ding, M.; Lin, F.-C.; Meyer, M. L.

2024-09-19 epidemiology
10.1101/2024.09.18.24313882 medRxiv
Show abstract

Multi-state Markov models have been used to model the course of chronic disease. However, they are unsuitable to chronic disease where past and present states interplay and affect future states, and the estimated transition probabilities are time-specific which are not straightforward for public health interpretation. We have proposed a multi-state non-Markov framework that splits disease states into substates conditioning on past states. As the substates track past states and indicate multimorbidity, the estimated transition rates can be used to derive two summary estimates: Disease path which shows path of state transition, and multimorbidity-adjusted life year (MALY) which represents the adjusted life year in full health. In this paper, we showed the derivation of the two summary estimates and applied them to characterize the course of heart disease using data from the Atherosclerosis Risk in Communities Study (ARIC) study. The course of heart disease was modeled in five states, namely, healthy, at metabolic risk, coronary heart disease (CHD), heart failure, and mortality. In this mid- to old-age population, the estimated MALY was 24.13 (95% CI: 16.55, 32.06) years. For healthy participants at baseline, the most likely disease paths were: "Healthy [->] at metabolic risk [->] mortality" (37%), "Healthy [->] mortality" (21%), "Healthy [->] at metabolic risk [->] heart failure [->] mortality" (19%), and "Healthy [->] at metabolic risk [->] CHD [->] mortality" (8%). The MALY was higher among women than men and higher among Whites than Blacks. The distribution of disease path was similar across sex and race subgroups. In summary, MALY and disease path characterize the disease course in a summary manner and have potential use in chronic disease prevention.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 13%
14.6%
2
European Journal of Epidemiology
40 papers in training set
Top 0.1%
14.3%
3
PLOS Computational Biology
1633 papers in training set
Top 3%
10.0%
4
American Journal of Epidemiology
57 papers in training set
Top 0.1%
8.4%
5
Scientific Reports
3102 papers in training set
Top 24%
4.8%
50% of probability mass above
6
BMC Medical Research Methodology
43 papers in training set
Top 0.2%
4.3%
7
Genetic Epidemiology
46 papers in training set
Top 0.2%
3.9%
8
Journal of Biomedical Informatics
45 papers in training set
Top 0.5%
3.6%
9
Epidemiology and Infection
84 papers in training set
Top 0.6%
3.6%
10
Journal of the American Heart Association
119 papers in training set
Top 3%
2.1%
11
International Journal of Epidemiology
74 papers in training set
Top 1%
1.7%
12
Epidemiology
26 papers in training set
Top 0.3%
1.7%
13
BMC Public Health
147 papers in training set
Top 4%
1.7%
14
Journal of Theoretical Biology
144 papers in training set
Top 1%
1.5%
15
PLOS Genetics
756 papers in training set
Top 10%
1.3%
16
Statistics in Medicine
34 papers in training set
Top 0.2%
1.3%
17
Journal of The Royal Society Interface
189 papers in training set
Top 3%
1.2%
18
eLife
5422 papers in training set
Top 49%
1.2%
19
BMC Infectious Diseases
118 papers in training set
Top 5%
0.8%
20
Nature Communications
4913 papers in training set
Top 64%
0.7%
21
Frontiers in Public Health
140 papers in training set
Top 9%
0.7%
22
JMIR Public Health and Surveillance
45 papers in training set
Top 4%
0.6%